RT Journal Article SR Electronic T1 Estradiol Facilitation of Cocaine Self-Administration in Female Rats Requires Activation of mGluR5 JF eneuro JO eNeuro FD Society for Neuroscience SP ENEURO.0140-16.2016 DO 10.1523/ENEURO.0140-16.2016 VO 3 IS 5 A1 Luis A. Martinez A1 Kellie S. Gross A1 Brett T. Himmler A1 Nicole L. Emmitt A1 Brittni M. Peterson A1 Natalie E. Zlebnik A1 M. Foster Olive A1 Marilyn E. Carroll A1 Robert L. Meisel A1 Paul G. Mermelstein YR 2016 UL http://www.eneuro.org/content/3/5/ENEURO.0140-16.2016.abstract AB In comparison to men, women initiate drug use at earlier ages and progress from initial use to addiction more rapidly. This heightened intake and vulnerability to drugs of abuse is regulated in part by estradiol, although the signaling mechanisms by which this occurs are not well understood. Recent findings indicate that within the nucleus accumbens core, estradiol induces structural plasticity via membrane-localized estrogen receptor α, functionally coupled to metabotropic glutamate receptor subtype 5 (mGluR5). Hence, we sought to determine whether mGluR5 activation was essential for estradiol-mediated enhancement of cocaine self-administration. Ovariectomized (OVX) female rats were allowed to freely self-administer cocaine under extended access conditions (6 h/d) for 10 consecutive days. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP) or vehicle was administered before estradiol (or oil), on a 2 d on/2 d off schedule throughout the extended access period. MPEP treatment prevented the estradiol-dependent enhancement of cocaine self-administration in OVX females. In a separate experiment, potentiation of mGluR5 function with the positive allosteric modulator 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (in the absence of estradiol treatment) failed to increase cocaine self-administration. These data suggest that mGluR5 activation is necessary for estradiol-mediated enhancement of responses to cocaine, but that direct mGluR5 activation is insufficient to mimic the female response to estradiol. Building on previous studies in male animals, these findings further highlight the therapeutic potential of mGluR5 antagonism in the treatment of addiction and suggest that there may be added therapeutic benefit in females.